SMO and medulloblastoma: As assay system we employed HH-responsive, SMO-inhibitor sensitive human medulloblastoma cells (DAOY) (Figure 1B) [38] and measured changes in the expression of the known HH target genes GLI1 and PTCH as quantitative read-out for pathway activity.